---
layout: post
title: SPTBN1
date: 2025-01-17 16:55 CST
description: SPTBN1 description
tags: [cooccuring-genes]
categories: unknown-mechanism
pretty_table: true
citation: true
related_posts: true
---



| [NCBI ID](https://www.ncbi.nlm.nih.gov/gene/6711) | NCBI symbol | ENSEMBL ID | Chromosome location |
| :-------- | :------- | :-------- | :------- |
| 6711  | SPTBN1 | ENSG00000115306 | 2p16.2 |



The gene is involved in various biological processes, including [mitotic cytokinesis](https://amigo.geneontology.org/amigo/term/GO:0000281), [plasma membrane organization](https://amigo.geneontology.org/amigo/term/GO:0007009), [central nervous system development](https://amigo.geneontology.org/amigo/term/GO:0007417), and [actin cytoskeleton organization](https://amigo.geneontology.org/amigo/term/GO:0030036). It enables several molecular functions such as [RNA binding](https://amigo.geneontology.org/amigo/term/GO:0003723), [actin binding](https://amigo.geneontology.org/amigo/term/GO:0003779), and [protein binding](https://amigo.geneontology.org/amigo/term/GO:0005515). The gene is located in multiple cellular components, including the [nucleolus](https://amigo.geneontology.org/amigo/term/GO:0005730), [cytoplasm](https://amigo.geneontology.org/amigo/term/GO:0005737), [cytosol](https://amigo.geneontology.org/amigo/term/GO:0005829), and [plasma membrane](https://amigo.geneontology.org/amigo/term/GO:0005886). Additionally, it is active in the [cell junction](https://amigo.geneontology.org/amigo/term/GO:0030054) and [cortical actin cytoskeleton](https://amigo.geneontology.org/amigo/term/GO:0030864). The gene is also part of [spectrin](https://amigo.geneontology.org/amigo/term/GO:0008091) and is involved in processes like [Golgi to plasma membrane protein transport](https://amigo.geneontology.org/amigo/term/GO:0043001) and [regulation of protein localization to plasma membrane](https://amigo.geneontology.org/amigo/term/GO:1903076).


The gene length is 4,910 base pairs (13.73% of all genes), the mature length is 762 base pairs, and the primary transcript length is 4,841.5 base pairs.


The gene SPTBN1 (NCBI ID: 6711) has been mentioned in [32 publications](https://pubmed.ncbi.nlm.nih.gov/?term=%22SPTBN1%22) according to [Pubtator](https://academic.oup.com/nar/article/47/W1/W587/5494727), with the earliest publication in 1990 and the middle 50% of publications occurring between 2005 and 2020. Note that the publication count in the hyperlink may be different since the count is from Pubtator.


The gene SPTBN1 has been extensively studied in various contexts, with notable publications highlighting its significance. The [Relative Citation Ratio (RCR)](https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002541) measures the scientific influence of each paper by field- and time-adjusting the citations it has received, benchmarking to the median for NIH publications, which is set at 1.0. The top publications mentioning SPTBN1 include "[Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome.](https://pubmed.ncbi.nlm.nih.gov/34211179)" (2021) (relative citation ratio: 3.15), "[Integrating GWAS and Co-expression Network Data Identifies Bone Mineral Density Genes SPTBN1 and MARK3 and an Osteoblast Functional Module.](https://pubmed.ncbi.nlm.nih.gov/27866947)" (2017) (relative citation ratio: 2.58), "[Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin.](https://pubmed.ncbi.nlm.nih.gov/9537418)" (1998) (relative citation ratio: 2.34), "[SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma.](https://pubmed.ncbi.nlm.nih.gov/33754058)" (2021) (relative citation ratio: 2.04), and "[Degradation of Î²II-Spectrin Protein by Calpain-2 and Caspase-3 Under Neurotoxic and Traumatic Brain Injury Conditions.](https://pubmed.ncbi.nlm.nih.gov/25270371)" (2015) (relative citation ratio: 1.67). Citation counts are sourced from [iCite](https://icite.od.nih.gov).


[SPTBN1](https://www.proteinatlas.org/ENSG00000115306-SPTBN1) is a gene with molecular functions including actin capping, actin-binding, and calmodulin-binding. It is involved in diseases such as intellectual disability and has evidence at the protein level. The gene is detected in all RNA tissue distributions and is primarily located in the cytosol. In terms of expression clusters, SPTBN1 is found in Cluster 43 for blood expression, Cluster 34 for tissue expression, Cluster 19 for brain expression, Cluster 53 for cell line expression, and Cluster 53 for single cell expression, indicating its involvement in various cellular processes and functions.


The top transcription factors (TFs) identified from GTRD's database of TF binding sites, based on the number of CHIP-seq experiments, include [ESR1](https://www.ncbi.nlm.nih.gov/gene/2099) with 7 experiments, [RAD21](https://www.ncbi.nlm.nih.gov/gene/5885) with 6 experiments, [MYCN](https://www.ncbi.nlm.nih.gov/gene/4613) with 5 experiments, [NR3C1](https://www.ncbi.nlm.nih.gov/gene/2908) with 5 experiments, and [FLI1](https://www.ncbi.nlm.nih.gov/gene/2313) with 5 experiments. These TFs have been shown to play significant roles in gene regulation, as evidenced by their frequent appearance in CHIP-seq data.


The top transcription factors (TFs) identified in terms of the number of Perturb-seq experiments are [23028](https://www.ncbi.nlm.nih.gov/gene/23028) and [8861](https://www.ncbi.nlm.nih.gov/gene/8861), with 2 and 3 experiments respectively. These TFs were found to regulate gene expression in multiple experiments, highlighting their significant role in transcriptional regulation.


The input data from GWAS indicates associations with a wide range of disease conditions, including various types of cancer such as breast cancer, thoracic cancer, male reproductive organ cancer, prostate cancer, testicular cancer, head and neck cancer, colorectal cancer, intestinal cancer, large intestine cancer, gastrointestinal system cancer, myeloid leukemia, acute myeloid leukemia, colon cancer, lung cancer, respiratory system cancer, leukemia, hematologic cancer, and immune system cancer. Additionally, the data highlights infectious diseases like diarrhea, hand, foot and mouth disease, and viral infectious diseases. Metabolic disorders such as diabetes mellitus, type 2 diabetes mellitus, and diseases of carbohydrate and glucose metabolism are also noted. Cardiovascular conditions include artery disease, vascular disease, cardiovascular system disease, hypertension, arteriosclerosis, arteriosclerotic cardiovascular disease, and atherosclerosis. Neurological and mental health conditions include neurodegenerative diseases, cognitive disorders, bipolar disorder, mood disorders, psychotic disorders, schizophrenia, and Parkinson's disease. Musculoskeletal and bone diseases such as arthritis, rheumatoid arthritis, bone inflammation disease, bone remodeling disease, and bone resorption disease are also present. Eye diseases like refractive error and myopia, as well as sleep disorders and mineral metabolism diseases, are included.



The gene is ubiquitously expressed in multiple tissue samples, including adipose tissue, nerve, and lung, as indicated by the BioGPS Human Cell Type and Tissue Gene Expression Profiles. Additionally, the GTEx Tissue Gene Expression Profiles show expression in various brain regions such as the Prefrontal Cortex, Whole Brain, Medulla Oblongata, Occipital Lobe, and Olfactory Bulb, as well as in the Lung.


The proteins are involved in several key pathways, including nephrin interactions, axon guidance, developmental biology, interaction between L1 and ankyrins, L1CAM interactions, NCAM signaling for neurite outgrowth, and cell-cell communication.



The analyzed protein sequence has a GRAVY value of -0.766 (13.41% percentile), indicating a hydrophilic nature. The charge at pH 7.0 is -83.83 (0.75% percentile), and the median structural flexibility is 1.009 (77.12% percentile). The protein has a high affinity for helix structures (40.06%, 93.49% percentile), with lower affinities for sheet (31.39%, 36.06% percentile) and turn (22.29%, 7.34% percentile) structures. The instability index is 47.85 (49.64% percentile), and the isoelectric point is 5.39 (15.63% percentile). The protein is relatively long with 2364 amino acids (98.43% percentile) and has a molecular weight of 274606 Da (98.63% percentile). For more details on the sequence analysis, refer to [BioPython's sequence analysis documentation](https://biopython.org/docs/1.75/api/Bio.SeqUtils.ProtParam.html).





| Checks    | Answer |
| :-------- | :------- |
| Sentiment  | neutral   |
| Ethical concerns | no     |
| Coherence    | no    |